New drug sponsors are increasingly interested in talking with US Food and Drug Administration officials about their development programs, making timely dates harder to find.
US FDA Struggles To Meet Goals As Drug Sponsors' Meeting Requests Rise
The FDA did not expect to meet many FY 2018 goals for on-time scheduling of formal PDUFA meetings or issuing written responses in lieu of meetings.
